Large-scale testing (Phase 3)Ended earlyNCT00796510
What this trial is testing
Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety
Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 3